NCT00038701终止2 期
Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients With Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 6
- 试验地点
- 1
- 主要终点
- Patient Survival Rate
研究概览
简要总结
The goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Gemzar Chemoradiation + TNP-470
Experimental
干预措施: TNP-470 (Drug)
结局指标
主要结局
Patient Survival Rate
时间窗: 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
撤回
2 期
Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic CancerCarcinoma, Pancreatic DuctalNCT00226746New York Presbyterian Brooklyn Methodist Hospital
已完成
2 期
MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung CancerNon Small Cell Lung CancerNCT00401492National Cancer Institute, Naples159
已完成
2 期
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerEndometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaRecurrent Uterine Corpus CarcinomaNCT00820898Gynecologic Oncology Group24
已完成
2 期
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial CarcinomaUrothelial CarcinomaNCT01261728Memorial Sloan Kettering Cancer Center57
已完成
1 期
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical CarcinomaUterine Cervical CancerNCT00184093University of Southern California35